Cargando…
Plasma gp96 is a Novel Predictive Biomarker for Severe COVID-19
Early and effective identification of severe coronavirus disease 2019 (COVID-19) may allow us to improve the outcomes of associated severe acute respiratory illness with fever and respiratory symptoms. This study analyzed plasma concentrations of heat shock protein gp96 in nonsevere (including mild...
Autores principales: | Wei, Rongguo, Zhou, Biyan, Li, Shaohua, Zhong, Debin, Li, Boan, Qin, Jianqiu, Zhao, Liping, Qin, Lixian, Hu, Jun, Wang, Jiuru, Yang, Shixiong, Zhao, Jingming, Meng, Songdong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8612155/ https://www.ncbi.nlm.nih.gov/pubmed/34817280 http://dx.doi.org/10.1128/Spectrum.00597-21 |
Ejemplares similares
-
Induction of Foxp3 and activation of Tregs by HSP gp96 for treatment of autoimmune diseases
por: Xu, Yuxiu, et al.
Publicado: (2021) -
Extracellular gp96 is a crucial mediator for driving immune hyperactivation and liver damage
por: Guan, Zeliang, et al.
Publicado: (2020) -
Placenta-derived gp96 as a multivalent prophylactic cancer vaccine
por: Zhao, Bao, et al.
Publicado: (2013) -
Chaperone gp96 mediates ER-α36 cell membrane expression
por: Hou, Junwei, et al.
Publicado: (2015) -
Induction of Regulatory T Cells by High-Dose gp96 Suppresses Murine Liver Immune Hyperactivation
por: Li, Xinghui, et al.
Publicado: (2013)